{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T17:11:12Z","timestamp":1780333872213,"version":"3.54.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T00:00:00Z","timestamp":1534982400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Nippon Boehringer Ingelheim Co., Ltd.","award":["Scholarship donation, number not available"],"award-info":[{"award-number":["Scholarship donation, number not available"]}]},{"name":"Pfizer Japan Inc.","award":["Scholarship donation, number not available"],"award-info":[{"award-number":["Scholarship donation, number not available"]}]},{"DOI":"10.13039\/100004324","name":"Astellas Pharma Inc.","doi-asserted-by":"crossref","award":["Scholarship donation, number not available"],"award-info":[{"award-number":["Scholarship donation, number not available"]}],"id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shionogi & Co., Ltd.","award":["Scholarship donation, number not available"],"award-info":[{"award-number":["Scholarship donation, number not available"]}]},{"DOI":"10.13039\/501100013126","name":"FP Pharmaceutical Corporation","doi-asserted-by":"crossref","award":["Scholarship donation, number not available"],"award-info":[{"award-number":["Scholarship donation, number not available"]}],"id":[{"id":"10.13039\/501100013126","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100012781","name":"MSD K.K.","doi-asserted-by":"crossref","award":["Scholarship donation, number not available"],"award-info":[{"award-number":["Scholarship donation, number not available"]}],"id":[{"id":"10.13039\/100012781","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Co., Ltd.","doi-asserted-by":"crossref","award":["Scholarship donation, number not available"],"award-info":[{"award-number":["Scholarship donation, number not available"]}],"id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s00702-018-1917-x","type":"journal-article","created":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T11:21:50Z","timestamp":1535023310000},"page":"1511-1514","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cerebrospinal fluid 5-HIAA concentrations correlate with cardiac uptake of 123I-MIBG during myocardial scintigraphy in drug na\u00efve Parkinson\u2019s disease"],"prefix":"10.1007","volume":"125","author":[{"given":"Hidetomo","family":"Murakami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Yasumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Sakae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Nomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satomi","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daishi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8454-6155","authenticated-orcid":false,"given":"Kenjiro","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,23]]},"reference":[{"key":"1917_CR1","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1136\/jnnp.40.12.1136","volume":"40","author":"DL Davidson","year":"1977","unstructured":"Davidson DL, Yates CM, Mawdsley C, Pullar IA, Wilson H (1977) CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders. J Neurol Neurosurg Psychiatry 40:1136\u20131141","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1917_CR2","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/0006-8993(90)90733-R","volume":"510","author":"GM Halliday","year":"1990","unstructured":"Halliday GM, Blumbergs PC, Cotton RG, Blessing WW, Geffen LB (1990) Loss of brainstem serotonin- and substance P-containing neurons in Parkinson\u2019s disease. Brain Res 510:104\u2013107","journal-title":"Brain Res"},{"key":"1917_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/j.1600-0404.2009.01255.x","volume":"122","author":"K Ishibashi","year":"2010","unstructured":"Ishibashi K, Kanemaru K, Saito Y, Murayama S, Oda K, Ishiwata K, Mizusawa H, Ishii K (2010) Cerebrospinal fluid metabolite and nigrostriatal dopaminergic function in Parkinson\u2019s disease. Acta Neurol Scand 122:46\u201351","journal-title":"Acta Neurol Scand"},{"key":"1917_CR4","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S0378-4347(00)86070-3","volume":"226","author":"MH Joseph","year":"1981","unstructured":"Joseph MH, Kadam BV, Risby D (1981) Simple high-performance liquid chromatographic method for the concurrent determination of the amine metabolites vanillylmandelic acid, 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, dihydroxyphenylacetic acid and homovanillic acid in urine using electrochemical detection. J Chromatogr 226:361\u2013368","journal-title":"J Chromatogr"},{"key":"1917_CR5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O\u2019Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M, Kosaka K (2017) Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology 89:88\u2013100","journal-title":"Neurology"},{"key":"1917_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0171524","author":"S Morimoto","year":"2017","unstructured":"Morimoto S, Takao M, Hatsuta H, Nishina Y, Komiya T, Sengoku R, Nakano Y, Uchino A, Sumikura H, Saito Y, Kanemaru K, Murayama S (2017) Homovanillic acid and 5-hydroxyindole acetic acid as biomarkers for dementia with Lewy bodies and coincident Alzheimer\u2019s disease: An autopsy-confirmed study. PLoS One. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0171524","journal-title":"PLoS One"},{"key":"1917_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2017.00321","author":"H Murakami","year":"2017","unstructured":"Murakami H, Nohara T, Uchiyama M, Owan Y, Futamura A, Shiromaru A, Tsukada S, Saito Y, Kuroda T, Yano S, Ishigaki S, Katoh H, Munechika J, Ohgiya Y, Gokan T, Ono K (2017) Accumulation of 123I-ioflupane is a useful marker of the efficacy of selegiline monotherapy in drug-na\u00efve Parkinson\u2019s disease. Front Aging Neurosci. \n                    https:\/\/doi.org\/10.3389\/fnagi.2017.00321","journal-title":"Front Aging Neurosci"},{"key":"1917_CR8","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1111\/j.1440-1681.2006.04521.x","volume":"33","author":"E Nalivaiko","year":"2006","unstructured":"Nalivaiko E (2006) 5-HT(1A) receptors in stress-induced cardiac changes: a possible link between mental and cardiac disorders. Clin Exp Pharmacol Physiol 33:1259\u20131264","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"1917_CR9","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.arr.2016.01.001","volume":"30","author":"S Orimo","year":"2016","unstructured":"Orimo S, Yogo M, Nakamura T, Suzuki M, Watanabe H (2016) (123)I-meta-iodobenzylguanidine (MIBG) cardiac scintigraphy in \u03b1-synucleinopathies. Ageing Res Rev 30:122\u2013133","journal-title":"Ageing Res Rev"},{"key":"1917_CR10","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.nbd.2010.05.028","volume":"40","author":"M Politis","year":"2010","unstructured":"Politis M, Wu K, Loane C, Kiferle L, Molloy S, Brooks DJ, Piccini P (2010) Staging of serotonergic dysfunction in Parkinson\u2019s disease: an in vivo 11C-DASB PET study. Neurobiol Dis 40:216\u2013221","journal-title":"Neurobiol Dis"},{"key":"1917_CR11","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30:1591\u20131601","journal-title":"Mov Disord"},{"key":"1917_CR12","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1136\/jnnp-2015-310686","volume":"86","author":"M Takahashi","year":"2015","unstructured":"Takahashi M, Ikemura M, Oka T, Uchihara T, Wakabayashi K, Kakita A, Takahashi H, Yoshida M, Toru S, Kobayashi T, Orimo S (2015) Quantitative correlation between cardiac MIBG uptake and remaining axons in the cardiac sympathetic nerve in Lewy body disease. J Neurol Neurosurg Psychiatry 86:939\u2013944","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1917_CR13","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1111\/j.1471-4159.1990.tb01942.x","volume":"54","author":"P Wester","year":"1990","unstructured":"Wester P, Bergstr\u00f6m U, Eriksson A, Gezelius C, Hardy J, Winblad B (1990) Ventricular cerebrospinal fluid monoamine transmitter and metabolite concentrations reflect human brain neurochemistry in autopsy cases. J Neurochem 54:1148\u20131156","journal-title":"J Neurochem"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-018-1917-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-018-1917-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-018-1917-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T00:57:48Z","timestamp":1589936268000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-018-1917-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,23]]},"references-count":13,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["1917"],"URL":"https:\/\/doi.org\/10.1007\/s00702-018-1917-x","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,23]]},"assertion":[{"value":"8 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare to have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Ethics Committee of Showa University School of Medicine approved this study, and it was performed in accordance with the Declaration of Helsinki. Written informed consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}